Delivery Order SPE2DB24D2205-SPE2DB25FEDDL

Award Date 6/3/25
Potential Completion Date 6/4/25
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $42,283.34, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order for the supply of PRIORIX VIALS, a medical product, with a completion date of January 8, 2024. This award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,235.50 firm fixed-price delivery order is for the supply of PRIORIX VIALS, a medical product, with a completion date of June 10, 2025. The contract is not set aside and is part of AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,014.62 firm fixed-price contract is for the supply of PRIORIX VIALS, with an ultimate completion date of October 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $24,271.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for PRIORIX VIALS, a medical product, with a completion date of March 3, 2025. The contract is a firm-fixed-price agreement and was not set aside for any specific business designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is a delivery order valued at $17,135.66 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of PRIORIX VIALS, a pharmaceutical product, with a completion date of November 27, 2024. The contract is a firm fixed-price agreement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
This federal contract award, valued at $24,395.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of PRIORIX VIALS, a medical product, with a completion date of June 13, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,047.10, is a Firm Fixed Price Delivery Order for the supply of PRIORIX VIALS, a medical product. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen, a for-profit organization, is the prime contractor and holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, with a ceiling value of $25,235.50, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of PRIORIX VIALS. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 7, 2025. This award is not set-aside and represents an open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite...
This federal contract award, valued at $1,361.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of PRIORIX VIALS, a medical product, with a completion date of May 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,879.00, is a firm fixed-price delivery order for PRIORIX VIALS. The award has an ultimate completion date of November 6, 2024 and was issued on November 5, 2024. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FEDDL
    Delivery Order

This federal contract award, valued at $25,235.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of PRIORIX VIALS, with a completion date of June 4, 2025. The award is not set-aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and the U.S. Coast Guard.

Generated 9/2/25, 9:49 AM